Evidence map›Paper›PMID 39108290›Full record

ArticleArXiv2024

Immunity to Increasing Condition Numbers of Linear Superiorization versus Linear Programming.

Jan Schröder, Yair Censor, Philipp Süss, Karl-Heinz Küfer

Abstract readPreprint
In one paragraph

Article in ArXiv, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jan SchröderOptimization Department, Fraunhofer - ITWM, Kaiserslautern 67663, Germany.
Yair CensorDepartment of Mathematics, University of Haifa, Mt. Carmel, Haifa 3498838, Israel.
Philipp SüssOptimization Department, Fraunhofer - ITWM, Kaiserslautern 67663, Germany.
Karl-Heinz KüferOptimization Department, Fraunhofer - ITWM, Kaiserslautern 67663, Germany.

Funding

Ionization Detail - Biologically based treatment planning for particle therapy beyond LET-RBER01CA266467 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUCE FADDEGON, Jian-Hua Mao · 2022 to 2026
$3.0M
NCI NIH HHS R01 CA266467
6 · The paper itself

Abstract

Given a family of linear constraints and a linear objective function one can consider whether to apply a Linear Programming (LP) algorithm or use a Linear Superiorization (LinSup) algorithm on this data. In the LP methodology one aims at finding a point that fulfills the constraints and has the minimal value of the objective function over these constraints. The Linear Superiorization approach considers the same data as linear programming problems but instead of attempting to solve those with linear optimization methods it employs perturbation resilient feasibility-seeking algorithms and steers them toward feasible points with reduced (not necessarily minimal) objective function values. Previous studies compared LP and LinSup in terms of their respective outputs and the resources they use. In this paper we investigate these two approaches in terms of their sensitivity to condition numbers of the system of linear constraints. Condition numbers are a measure for the impact of deviations in the input data on the output of a problem and, in particular, they describe the factor of error propagation when given wrong or erroneous data. Therefore, the ability of LP and LinSup to cope with increased condition numbers, thus with ill-posed problems, is an important matter to consider which was not studied until now. We investigate experimentally the advantages and disadvantages of both LP and LinSup on examplary problems of linear programming with multiple condition numbers and different problem dimensions.

Indexed as

bounded perturbationsCondition numberfeasibility seekingGurobiill-posed problemLinear ProgrammingLinear SuperiorizationScipy

Identifiers

PMID39108290
PMCPMC11302679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.